JPWO2021138682A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021138682A5
JPWO2021138682A5 JP2022541283A JP2022541283A JPWO2021138682A5 JP WO2021138682 A5 JPWO2021138682 A5 JP WO2021138682A5 JP 2022541283 A JP2022541283 A JP 2022541283A JP 2022541283 A JP2022541283 A JP 2022541283A JP WO2021138682 A5 JPWO2021138682 A5 JP WO2021138682A5
Authority
JP
Japan
Prior art keywords
seq
protein
pharmaceutical composition
active site
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022541283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509462A (ja
JP2023509462A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012109 external-priority patent/WO2021138682A1/en
Publication of JP2023509462A publication Critical patent/JP2023509462A/ja
Publication of JPWO2021138682A5 publication Critical patent/JPWO2021138682A5/ja
Publication of JP2023509462A5 publication Critical patent/JP2023509462A5/ja
Priority to JP2025116559A priority Critical patent/JP2025182217A/ja
Pending legal-status Critical Current

Links

JP2022541283A 2020-01-03 2021-01-04 チオレドキシン活性を有する組成物および関連方法 Pending JP2023509462A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025116559A JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062956994P 2020-01-03 2020-01-03
US62/956,994 2020-01-03
PCT/US2021/012109 WO2021138682A1 (en) 2020-01-03 2021-01-04 Compositions having thioredoxin activity and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025116559A Division JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Publications (3)

Publication Number Publication Date
JP2023509462A JP2023509462A (ja) 2023-03-08
JPWO2021138682A5 true JPWO2021138682A5 (https=) 2024-08-27
JP2023509462A5 JP2023509462A5 (https=) 2024-08-27

Family

ID=76687128

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022541283A Pending JP2023509462A (ja) 2020-01-03 2021-01-04 チオレドキシン活性を有する組成物および関連方法
JP2025116559A Pending JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025116559A Pending JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Country Status (6)

Country Link
US (1) US20230071765A1 (https=)
EP (1) EP4084867A4 (https=)
JP (2) JP2023509462A (https=)
CN (1) CN115315292A (https=)
CA (1) CA3163157A1 (https=)
WO (1) WO2021138682A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9168290B2 (en) 2013-03-15 2015-10-27 Orpro Therapeutics, Inc. Product and process for mucus viscosity normalization
AU2021298391A1 (en) * 2020-06-23 2023-02-02 Panasonic Intellectual Property Management Co., Ltd. Method of inactivating allergen and allergen inactivation device
EP4553160A1 (en) * 2022-07-05 2025-05-14 Tohoku University Antiviral agent, pharmaceutical composition for treating or preventing viral infection, kit for evaluating risk of viral infection becoming severe, and method for evaluating risk of viral infection becoming severe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
JPH10191977A (ja) * 1997-01-14 1998-07-28 Oriental Yeast Co Ltd チオレドキシン改変体及び該改変体を含むａｐ−１の転写活性能を増強する因子
JP4758525B2 (ja) * 1998-03-20 2011-08-31 武田薬品工業株式会社 生理活性ポリペプチドの徐放性製剤およびその製造法
US20060148057A1 (en) * 2002-08-02 2006-07-06 Wang Min Thioredoxin mutants and uses thereof
US20090075871A2 (en) * 2003-03-31 2009-03-19 National Institute Of Advanced Industrial Science And Technology Modified Thioredoxin
US20090203586A1 (en) * 2004-06-11 2009-08-13 Syngenta Limited Method for ameliorating an inflammatory skin condition
AU2012255132B2 (en) * 2011-05-17 2017-05-25 Soligenix, Inc. Thermostable vaccine compositions and methods of preparing same
US9168290B2 (en) * 2013-03-15 2015-10-27 Orpro Therapeutics, Inc. Product and process for mucus viscosity normalization
US20210213134A1 (en) * 2018-05-17 2021-07-15 Orpro Therapeutics, Inc. Thiol-based multivalent drug delivery compositions

Similar Documents

Publication Publication Date Title
JP7759693B2 (ja) モンテルカストおよびペプチドの新規接合体
JP4271730B2 (ja) ウリジン三リン酸及び関連化合物による線毛ジスキネシアの治療方法
RU2472524C2 (ru) Альфа-1-антитрипсин для лечения эпизодов обострения болезней легких
JP2005532988A (ja) 呼吸上皮の病変を治療するための方法および組成物
JP2024010006A5 (https=)
JP4110329B2 (ja) ウィルスのエアロゾールの調製方法
JP2012500091A5 (https=)
US20090227511A1 (en) Methods and compositions for treating lesions of the respiratory epithelium
JP2026000993A (ja) 新ペプチド
JP2004511515A (ja) 嚢胞性繊維症におけるエアロゾル化されたｓ−ニトロソグルタチオンの治療的使用
RU2016136449A (ru) Применение олигометов альгината в лечении муковисцидоза и других состояний, ассоциированных с нарушенной функцией ионных каналов cftr
JP2023126658A5 (https=)
Baugh et al. Infectious croup: a critical review
JPWO2021138682A5 (https=)
JPWO2020052677A5 (https=)
WO2012064601A1 (en) Methods of treating and preventing rhinovirus infection
WO2020143744A1 (en) New formulations containing leukotriene receptor antagonists
JPWO2021191592A5 (https=)
JPWO2022081711A5 (https=)
JPWO2021184062A5 (https=)
SK119896A3 (en) Inhibitors of clary tryptase, therapeutical and preventive means and their use
Busey et al. The Treatment of Cystic Fibrosis: A Statement by the Committee on Therapy
Sethi et al. Evidence based treatment of bronchiolitis
NZ793633B2 (en) Antimicrobial compounds, compositions, and uses thereof
JPWO2021222740A5 (https=)